Home Podcasts The 2 Minute Medicine® Podcast
The 2 Minute Medicine® Podcast

The 2 Minute Medicine® Podcast

2 Minute Medicine® 77 Episodes Sep 11, 2026

The 2 Minute Medicine Podcast summarizes the latest medical studies and health care research, curated and written by practicing physicians. Episodes are released twice a month and cover recent developments in clinical research and health news. The show is produced by 2 Minute Medicine, an organization founded in 2013. More content, including study summaries, visual abstracts, and a newsletter, is available on their website.

Episodes

The 2 Minute Medicine® Podcast – Opioid Treatment, Menopause Cocktail, Maxxing Trends, Ebola, and Coffee & Body Composition
The 2 Minute Medicine® Podcast – Opioid Treatment, Menopause Cocktail, Maxxing Trends, Ebola, and Coffee & Body Composition Sep 11, 2026 00:12:46 In this episode, we look at how social media continues to shape the way patients think about their health, for better and for worse. This week’s article comes from JAMA Network Open and is entitled “Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors”.After discussing this article, we begin with a conversation about the online "menopause cocktail" trend combining Allegra and
The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face”
The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face” Jul 1, 2026 00:04:57 In this episode, we explore how artificial intelligence is continuing to move deeper into healthcare infrastructure and clinical practice. We begin with the Food and Drug Administration's review of an artificial intelligence tool designed to predict drug-induced liver injury during drug development. We then examine a new certification program launched by The Joint Commission focused on respons
The 2 Minute Medicine® Podcast - Shingles Vaccine & Dementia Risk, Whole-Body MRI Scans, Andes Hantavirus, GLP-1 Emotional Blunting, and "Cortisol Face"
The 2 Minute Medicine® Podcast - Shingles Vaccine & Dementia Risk, Whole-Body MRI Scans, Andes Hantavirus, GLP-1 Emotional Blunting, and "Cortisol Face" Jun 24, 2026 00:08:32 In this episode, we explore how social media, celebrity influence, and emerging science continue to shape healthcare conversations around the world. The article of the week comes from from Annals of Internal Medicine entitled “Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay: A Target Trial Emulation.” In the second half, we take
The 2 Minute Medicine® Podcast- Asundexian for Secondary Stroke Prevention, “Fibermaxxing,” Red Light Therapy, Mouth Taping Risks, and WHO Schizophrenia Care Initiative Summary
The 2 Minute Medicine® Podcast- Asundexian for Secondary Stroke Prevention, “Fibermaxxing,” Red Light Therapy, Mouth Taping Risks, and WHO Schizophrenia Care Initiative Summary May 7, 2026 00:07:03 In this episode, we explore how social media and celebrity influence are reshaping health behaviors at scale. The article of the week comes from the New England Journal of Medicine and is entitled “Asundexian for secondary stroke prevention.”We start with the viral “Fibermaxxing” trend and its growing focus on microbiome health and satiety. We then examine how Jennifer Aniston’s longevity campaign
The 2 Minute Medicine® Podcast- Talzenna in Prostate Cancer, Safer Anticoagulation Strategies, Retatrutide’s Metabolic Impact, and FDA Oversight of GLP-1 Therapies Summary:
The 2 Minute Medicine® Podcast- Talzenna in Prostate Cancer, Safer Anticoagulation Strategies, Retatrutide’s Metabolic Impact, and FDA Oversight of GLP-1 Therapies Summary: May 7, 2026 00:04:51 In this episode of the 2 Minute Medicine® Podcast, we explore major advances in precision medicine, beginning with the Phase 3 TALAPRO-3 trial demonstrating improved outcomes with talazoparib combined with enzalutamide in metastatic prostate cancer. We review new evidence from the COBRRA trial comparing apixaban and rivaroxaban, highlighting a significantly improved bleeding profile without loss o
The 2 Minute Medicine® Podcast- Roche’s AI Factory, Amazon’s Health Assistant, Surgical Robotics Breakthroughs, and Chatbot Safety Concerns
The 2 Minute Medicine® Podcast- Roche’s AI Factory, Amazon’s Health Assistant, Surgical Robotics Breakthroughs, and Chatbot Safety Concerns Apr 23, 2026 00:19:34 In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the rapid transformation of artificial intelligence across the healthcare landscape, beginning with Roche’s launch of a large-scale AI factory designed to accelerate drug discovery and manufacturing. We review how NVIDIA-powered systems and “Lab-in-the-Loop” models are enabling real-time refinement of biological predic
The 2 Minute Medicine® Podcast- Breast Cancer Awareness Surge, NVIDIA’s AI Moment, New Strength Training Guidelines, and Cosmetic Surgery Safety Alert
The 2 Minute Medicine® Podcast- Breast Cancer Awareness Surge, NVIDIA’s AI Moment, New Strength Training Guidelines, and Cosmetic Surgery Safety Alert Apr 9, 2026 00:06:47 In this episode of the 2 Minute Medicine® Podcast, we explore a major public health moment as White House Chief of Staff Susie Wiles’ breast cancer diagnosis drives a national surge in screening awareness and reinforces the importance of early detection. We review new data on firearm acquisition trends following the COVID-19 pandemic, highlighting shifting demographics and implications for public
The 2 Minute Medicine® Podcast- The GLP-1 Revolution: Wegovy Pill, Lilly’s Orforglipron, and the Future of Oral Obesity Therapies
The 2 Minute Medicine® Podcast- The GLP-1 Revolution: Wegovy Pill, Lilly’s Orforglipron, and the Future of Oral Obesity Therapies Mar 4, 2026 00:07:15 In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the remarkable evolution of GLP-1 receptor agonists from injectable diabetes therapies to some of the most influential drugs in modern medicine. We review the landmark clinical trials behind semaglutide and tirzepatide that transformed expectations for medical weight loss. The episode then examines the emerging race to
The 2 Minute Medicine® Podcast- FDA Approvals, Transplant Breakthroughs, Gene Therapy Manufacturing, and ADC Safety Signals
The 2 Minute Medicine® Podcast- FDA Approvals, Transplant Breakthroughs, Gene Therapy Manufacturing, and ADC Safety Signals Feb 11, 2026 00:06:05 This Pharma Roundup episode reviews four major regulatory and clinical developments shaping early 2026. It begins with the Food and Drug Administration approval of Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for uncomplicated gonorrhea offering a needle-free alternative amid rising antimicrobial resistance. The episode then covers the approval of Yartemlea for hematopoietic stem ce
The 2 Minute Medicine® Podcast- One-Dose HPV Vaccines, Oral Semaglutide, AI Deepfake Doctors, and Longevity Tech from CES 2026
The 2 Minute Medicine® Podcast- One-Dose HPV Vaccines, Oral Semaglutide, AI Deepfake Doctors, and Longevity Tech from CES 2026 Jan 29, 2026 00:07:34 In this episode, we lead with our article of the week from the New England Journal of Medicine examining the noninferiority of a single-dose HPV vaccine compared with the standard two-dose regimen. We then dive into a detailed edition of The Scan, discussing how oral semaglutide is reshaping routine obesity visits and the real-world challenges of daily medication adherence. The conversation turns
The 2 Minute Medicine® Podcast- Pharma Roundup 10/15
The 2 Minute Medicine® Podcast- Pharma Roundup 10/15 Oct 17, 2025 00:06:26 In this episode of the 2 Minute Medicine Podcast: Pharma Roundup, we explore how innovation, regulation, and global strategy are reshaping the pharmaceutical landscape. We begin with the FDA’s approval of Enbumyst, the first intranasal loop diuretic for edema, offering patients with heart, kidney, or liver disease a faster and more convenient alternative to oral or intravenous therapy. Next, we tu
The 2 Minute Medicine® Podcast- AI Roundup 4
The 2 Minute Medicine® Podcast- AI Roundup 4 Oct 15, 2025 00:05:26 In this episode of the 2 Minute Medicine Podcast: AI Roundup, we examine how artificial intelligence is rapidly transitioning from research to real-world medical impact. We begin with Eli Lilly’s launch of TuneLab, a billion-dollar federated AI platform that opens the company’s research models to smaller biotech partners, marking a major shift toward collaborative drug discovery. Next, we explore

Recommended